Brewin Dolphin Wealth Management’s Twist Bioscience TWST Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$6K	Buy	+165	New	+$5.84K	﹤0.01%	306

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Brewin Dolphin Wealth Management's TWST Position: Q2 2022 in Review

Brewin Dolphin Wealth Management opened a new position in Twist Bioscience (TWST) in Q2 2022: 165 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #306 among its holdings.

204 funds tracked by Wall St. Rank hold TWST as of Q2 2022.

Brewin Dolphin Wealth Management held 165 shares of Twist Bioscience worth $6K as of Q2 2022.
Twist Bioscience was a new Brewin Dolphin Wealth Management position in Q2 2022.
Twist Bioscience made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #306 holding.
204 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.